Comparative Analysis of Cardiovascular Disorders in Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitor Therapy

Comparative Analysis of Cardiovascular Disorders in Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitor Therapy

Aim. To analyze adverse cardiovascular events in chronic myeloid leukemia (CML) patients who received various tyrosine kinase inhibitors (TKI). Materials & Methods. The trial included 97 CML patients with nilotinib, dasatinib or imatinib indications. By the time of examination the patients had...

Full description

Bibliographic Details
Main Authors: LM Makeeva, EI Emelina, AV Bykova, GE Gendlin, GA Gusarova, IG Nikitin, EYu Chelysheva, OYu Vinogradova, IE Lazarev, EG Arshanskaya, AG Turkina
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2019-12-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
imatinib
dasatinib
nilotinib
chronic myeloid leukemia
qtc prolongation
sudden cardiac death
peripheral occlusive disease of lower extremities
chronic heart failure
cardiomyopathy
pulmonary arterial hypertension
Online Access: http://bloodjournal.ru/wp-content/uploads/2019/12/10.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2019/12/10.pdf

Similar Items